Skeletal Muscle Mass and Physical Function during Neoadjuvant Therapy for Pancreatic Cancer: A Multimodal Prehabilitation Approach
- PMID: 41244940
- PMCID: PMC12615143
- DOI: 10.2490/prm.20250033
Skeletal Muscle Mass and Physical Function during Neoadjuvant Therapy for Pancreatic Cancer: A Multimodal Prehabilitation Approach
Keywords: chemoradiotherapy; pancreatic neoplasm; physical capability; striated muscles.
Conflict of interest statement
CONFLICTS OF INTEREST: The authors declare no conflict of interest.
Figures
References
-
- Takahashi S,Ohno I,Ikeda M,Konishi M,Kobayashi T,Akimoto T,Kojima M,Morinaga S,Toyama H,Shimizu Y,Miyamoto A,Tomikawa M,Takakura N,Takayama W,Hirano S,Otsubo T,Nagino M,Kimura W,Sugimachi K,Uesaka K: Neoadjuvant S-1 with concurrent radiotherapy followed by surgery for borderline resectable pancreatic cancer: a phase II open-label multicenter prospective trial (JASPAC05). Ann Surg 2022;276:e510–e517. 10.1097/SLA.0000000000004535 - DOI - PubMed
-
- Paiella S,Azzolina D,Trestini I,Malleo G,Nappo G,Ricci C,Ingaldi C,Vacca PG,De Pastena M,Secchettin E,Zamboni G,Maggino L,Corciulo MA,Sandini M,Cereda M,Capretti G,Casadei R,Bassi C,Mansueto G,Gregori D,Milella M,Zerbi A,Gianotti L,Salvia R: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis. Front Nutr 2023;10:1065294. 10.3389/fnut.2023.1065294 - DOI - PMC - PubMed
